Alterity Therapeutics Limited American Depositary Shares (ATHE) is a publicly traded Healthcare sector company. As of October 5, 2026, ATHE trades at $3.25 with a market cap of $62.82M and a P/E ratio of 0.00. ATHE moved -5.88% today. Year to date, ATHE is +12.01%; over the trailing twelve months it is -17.66%. Its 52-week range spans $2.52 to $7.00. Analyst consensus is strong buy with an average price target of $12.67. Rallies surfaces ATHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ATHE, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.25 |
| Market Cap | $62.82M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.00 |
| 52-Week Low | $2.52 |
| Volume | 85 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover ATHE: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.67.